RXi Pharmaceuticals Corp is a biotechnology company focused on discovering and developing therapies addressing high unmet medical needs, in the areas of dermatology and ophthalmology.
RXi Pharmaceuticals to Present at the Association for Research in Vision and Ophthalmology 2016 Annual Meeting MARLBOROUGH, Mass., April 18, 2016 /PRNewswire/ --RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics in dermatology and ophthalmology that address significant unmet medical needs, announced today that it will present at the Association for Research in Vision and Ophthalmology (ARVO) 2016 annual meeting. This meeting is the largest gathering of eye and vision researchers in the world drawing 11,000 attendees exploring cutting-edge science. This year's conference will be held May 1-5, 2016 at the Washington State Convention Center in Seattle, Washington.
